Literature DB >> 12235369

Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect.

Martin O Bergo1, Bryant Gavino, Jed Ross, Walter K Schmidt, Christine Hong, Lonnie V Kendall, Andreas Mohr, Margarita Meta, Harry Genant, Yebin Jiang, Erik R Wisner, Nicholas Van Bruggen, Richard A D Carano, Susan Michaelis, Stephen M Griffey, Stephen G Young.   

Abstract

Zmpste24 is an integral membrane metalloproteinase of the endoplasmic reticulum. Biochemical studies of tissues from Zmpste24-deficient mice (Zmpste24(-/-)) have indicated a role for Zmpste24 in the processing of CAAX-type prenylated proteins. Here, we report the pathologic consequences of Zmpste24 deficiency in mice. Zmpste24(-/-) mice gain weight slowly, appear malnourished, and exhibit progressive hair loss. The most striking pathologic phenotype is multiple spontaneous bone fractures-akin to those occurring in mouse models of osteogenesis imperfecta. Cortical and trabecular bone volumes are significantly reduced in Zmpste24(-/-) mice. Zmpste24(-/-) mice also manifested muscle weakness in the lower and upper extremities, resembling mice lacking the farnesylated CAAX protein prelamin A. Prelamin A processing was defective both in fibroblasts lacking Zmpste24 and in fibroblasts lacking the CAAX carboxyl methyltransferase Icmt but was normal in fibroblasts lacking the CAAX endoprotease Rce1. Muscle weakness in Zmpste24(-/-) mice can be reasonably ascribed to defective processing of prelamin A, but the brittle bone phenotype suggests a broader role for Zmpste24 in mammalian biology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235369      PMCID: PMC130584          DOI: 10.1073/pnas.192460799

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Subcellular localization and partial purification of prelamin A endoprotease: an enzyme which catalyzes the conversion of farnesylated prelamin A to mature lamin A.

Authors:  F Kilic; D A Johnson; M Sinensky
Journal:  FEBS Lett       Date:  1999-04-30       Impact factor: 4.124

2.  Transgenic mouse model of the mild dominant form of osteogenesis imperfecta.

Authors:  J Bonadio; T L Saunders; E Tsai; S A Goldstein; J Morris-Wiman; L Brinkley; D F Dolan; R A Altschuler; J E Hawkins; J F Bateman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Systematic genetic analysis with ordered arrays of yeast deletion mutants.

Authors:  A H Tong; M Evangelista; A B Parsons; H Xu; G D Bader; N Pagé; M Robinson; S Raghibizadeh; C W Hogue; H Bussey; B Andrews; M Tyers; C Boone
Journal:  Science       Date:  2001-12-14       Impact factor: 47.728

4.  Biochemical studies of Zmpste24-deficient mice.

Authors:  G K Leung; W K Schmidt; M O Bergo; B Gavino; D H Wong; A Tam; M N Ashby; S Michaelis; S G Young
Journal:  J Biol Chem       Date:  2001-06-08       Impact factor: 5.157

5.  Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifuss muscular dystrophy.

Authors:  C A Brown; R W Lanning; K Q McKinney; A R Salvino; E Cherniske; C A Crowe; B T Darras; S Gominak; C R Greenberg; C Grosmann; P Heydemann; J R Mendell; B R Pober; T Sasaki; F Shapiro; D A Simpson; O Suchowersky; J E Spence
Journal:  Am J Med Genet       Date:  2001-09-01

6.  Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice.

Authors:  Alberto M Pendás; Zhongjun Zhou; Juan Cadiñanos; José M P Freije; Jianming Wang; Kjell Hultenby; Aurora Astudillo; Annika Wernerson; Francisco Rodríguez; Karl Tryggvason; Carlos López-Otín
Journal:  Nat Genet       Date:  2002-04-01       Impact factor: 38.330

7.  Isoprenylcysteine carboxyl methyltransferase deficiency in mice.

Authors:  M O Bergo; G K Leung; P Ambroziak; J C Otto; P J Casey; A Q Gomes; M C Seabra; S G Young
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

8.  Yeast genes controlling responses to topogenic signals in a model transmembrane protein.

Authors:  Donald J Tipper; Carol A Harley
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

9.  Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene.

Authors:  A Stacey; J Bateman; T Choi; T Mascara; W Cole; R Jaenisch
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

10.  Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy.

Authors:  T Sullivan; D Escalante-Alcalde; H Bhatt; M Anver; N Bhat; K Nagashima; C L Stewart; B Burke
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

View more
  176 in total

Review 1.  Understanding the roles of nuclear A- and B-type lamins in brain development.

Authors:  Stephen G Young; Hea-Jin Jung; Catherine Coffinier; Loren G Fong
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

2.  Protein isoprenylation regulates osteogenic differentiation of mesenchymal stem cells: effect of alendronate, and farnesyl and geranylgeranyl transferase inhibitors.

Authors:  G Duque; C Vidal; D Rivas
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

3.  Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA.

Authors:  Hea-Jin Jung; Catherine Coffinier; Youngshik Choe; Anne P Beigneux; Brandon S J Davies; Shao H Yang; Richard H Barnes; Janet Hong; Tao Sun; Samuel J Pleasure; Stephen G Young; Loren G Fong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 4.  Skin Disease in Laminopathy-Associated Premature Aging.

Authors:  Tomás McKenna; Agustín Sola Carvajal; Maria Eriksson
Journal:  J Invest Dermatol       Date:  2015-07-29       Impact factor: 8.551

5.  Saccharomyces cerevisiae a-factor mutants reveal residues critical for processing, activity, and export.

Authors:  Gregory Huyer; Amy Kistler; Franklin J Nouvet; Carolyn M George; Meredith L Boyle; Susan Michaelis
Journal:  Eukaryot Cell       Date:  2006-09

Review 6.  Laminopathies: multiple disorders arising from defects in nuclear architecture.

Authors:  Veena K Parnaik; Kaliyaperumal Manju
Journal:  J Biosci       Date:  2006-09       Impact factor: 1.826

Review 7.  Therapeutic intervention based on protein prenylation and associated modifications.

Authors:  Michael H Gelb; Lucas Brunsveld; Christine A Hrycyna; Susan Michaelis; Fuyuhiko Tamanoi; Wesley C Van Voorhis; Herbert Waldmann
Journal:  Nat Chem Biol       Date:  2006-10       Impact factor: 15.040

8.  Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy.

Authors:  V Cenni; P Sabatelli; E Mattioli; S Marmiroli; C Capanni; A Ognibene; S Squarzoni; N M Maraldi; G Bonne; M Columbaro; L Merlini; G Lattanzi
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

Review 9.  Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease.

Authors:  Graham F Brady; Raymond Kwan; Juliana Bragazzi Cunha; Jared S Elenbaas; M Bishr Omary
Journal:  Gastroenterology       Date:  2018-03-13       Impact factor: 22.682

Review 10.  The role of lamin A/C in mesenchymal stem cell differentiation.

Authors:  Bo Zhang; Yang Yang; Reziwan Keyimu; Jin Hao; Zhihe Zhao; Rui Ye
Journal:  J Physiol Biochem       Date:  2019-01-31       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.